This information was provided by prnewswire
Send your Press Release here.
TSX:IN
OTCQX:IMLFF
VANCOUVER, Nov. 5, 2018 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, will report financial results for the three months ended September 30, 2018, which is the Company’s first quarter of fiscal year 2019 (“1Q19”), on Monday, November 12, 2018.
Conference Call & Webcast:
Monday, November 12, 2018 at 10:00 AM Pacific Time, 1:00 PM Eastern Time
| Toronto: | +1-416-764-8688 |
| Vancouver: | +1-778-383 7413 |
| North America (Toll Free): | +1-888-390 0546 |
| Conference ID: | 01602924 |
| Webcast: | https://event.on24.com/wcc/r/ |
Replays, Available through November 19, 2018:
| Toronto: | +1-416-764-8677 |
| North America (Toll Free): | +1-888-390-0541 |
| Playback Passcode: | 602924# |
The Company’s full financial statements and related MD&A for the three months ended September 30, 2018 will be available at www.sedar.com on November 12, 2018.
Leave a Reply